© 1995 American Heart Association, Inc.
Articles |
LDL Physical and Chemical Properties in Familial Combined Hyperlipidemia
Presented in part at the annual meeting of the American Society for Clinical Investigation, Washington, DC, May 4, 1984.
From the Division of Metabolism, Endocrinology, and Nutrition, Department of Medicine (J.E.H., J.J.A., J.D.B.), and the Department of Epidemiology, School of Public Health and Community Medicine (J.E.H., M.A.A.), University of Washington, Seattle, and the Donner Laboratory, Lawrence Berkeley Laboratory, University of California (R.M.K.), Berkeley.
Abstract Familial combined hyperlipidemia (FCHL) is characterized by elevations of triglyceride and/or cholesterol within families and an elevation in apoB. Although small dense LDL has been consistently associated with hypertriglyceridemia, small dense LDL persists despite reductions in triglyceride after treatment with gemfibrozil in FCHL. The current study evaluated potential differences in the distribution and chemical composition of LDL species in patients with FCHL and normolipidemic control subjects. LDL from FCHL patients was characterized by a relative abundance of a discrete LDL species with a mean peak analytic ultracentrifuge flotation rate (S°f) of 4.7±0.5 (SEM), a density of 1.041±0.001 g/mL, and a particle diameter of 250±1 Å as assessed by gradient gel electrophoresis. The major LDL species in the control subjects had a higher mean S°f rate (6.3±0.4), was more buoyant (density, 1.037±0.001 g/mL), and was larger (diameter, 262±2 Å). In addition, in a series of six LDL fractions separated by equilibrium density gradient ultracentrifugation, particle diameters were significantly smaller in all fractions from FCHL patients compared with those from control subjects. LDL particles from patients contained less free cholesterol, cholesteryl ester, and phospholipid than LDL from control subjects. The amount of triglyceride per LDL particle, however, did not differ between FCHL patients and control subjects. Differences in flotation rate and mass of the major LDL species between patients and control subjects could not be fully accounted for by differences in plasma triglyceride levels. Thus, LDL particles from FCHL patients are smaller and more dense with less cholesterol and phospholipid. Many of these differences appear to be independent of plasma triglyceride. Differences in LDL physical and chemical properties may contribute to the increase in premature coronary disease in FCHL.
Key Words: LDL • apoB • gradient gel electrophoresis • triglyceride • density gradient ultracentrifugation • familial combined hyperlipidemia
This article has been cited by other articles:
 |
|
 |
|
  Y. Henkin Re-Evaluating Therapeutic Target Goals for Statin-Treated Patients: Time for Revolutionary Changes? J. Am. Coll. Cardiol., August 19, 2008; 52(8): 633 - 635. [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Veerkamp, J. de Graaf, J. C.M. Hendriks, P. N.M. Demacker, and A. F.H. Stalenhoef Nomogram to Diagnose Familial Combined Hyperlipidemia on the Basis of Results of a 5-Year Follow-Up Study Circulation, June 22, 2004; 109(24): 2980 - 2985. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A.M. Georgieva, M.M.J. van Greevenbroek, R.M. Krauss, M.C.G.J. Brouwers, V.M.M.-J. Vermeulen, M.G. Robertus-Teunissen, C.J.H. van der Kallen, and T.W.A. de Bruin Subclasses of Low-Density Lipoprotein and Very Low-Density Lipoprotein in Familial Combined Hyperlipidemia: Relationship to Multiple Lipoprotein Phenotype Arterioscler Thromb Vasc Biol, April 1, 2004; 24(4): 744 - 749. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.C. Shoulders, E.L. Jones, and R.P. Naoumova Genetics of familial combined hyperlipidemia and risk of coronary heart disease Hum. Mol. Genet., April 1, 2004; 13(90001): R149 - 160. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Ueno, J. Tremblay, J. Kunes, J. Zicha, Z. Dobesova, Z. Pausova, A. Y. Deng, Y.-L. Sun, H. J. Jacob, and P. Hamet Rat model of familial combined hyperlipidemia as a result of comparative mapping Physiol Genomics, March 12, 2004; 17(1): 38 - 47. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Soro, M. Jauhiainen, C. Ehnholm, and M.-R. Taskinen Determinants of low HDL levels in familial combined hyperlipidemia J. Lipid Res., August 1, 2003; 44(8): 1536 - 1544. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Veerkamp, J. de Graaf, S. J.H. Bredie, J. C.M. Hendriks, P. N.M. Demacker, and A. F.H. Stalenhoef Diagnosis of Familial Combined Hyperlipidemia Based on Lipid Phenotype Expression in 32 Families: Results of a 5-Year Follow-Up Study Arterioscler Thromb Vasc Biol, February 1, 2002; 22(2): 274 - 282. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. T.P. Keulen, M. Kruijshoop, N. C. Schaper, A. P.G. Hoeks, and T. W.A. de Bruin Increased Intima-Media Thickness in Familial Combined Hyperlipidemia Associated With Apolipoprotein B Arterioscler Thromb Vasc Biol, February 1, 2002; 22(2): 283 - 288. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Pihlajamaki, M. Austin, K. Edwards, and M. Laakso A Major Gene Effect on Fasting Insulin and Insulin Sensitivity in Familial Combined Hyperlipidemia Diabetes, October 1, 2001; 50(10): 2396 - 2401. [Abstract] [Full Text]
|
|
|
|
 |
|
 T. Kearney, C. Navas de Gallegos, A. Chrisoulidou, R. Gray, P. Bannister, S. Venkatesan, and D. G. Johnston Hypopituitarsim Is Associated with Triglyceride Enrichment of Very Low-Density Lipoprotein J. Clin. Endocrinol. Metab., August 1, 2001; 86(8): 3900 - 3906. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Q. Purnell, S. E. Kahn, R. S. Schwartz, and J. D. Brunzell Relationship of Insulin Sensitivity and ApoB Levels to Intra-abdominal Fat in Subjects With Familial Combined Hyperlipidemia Arterioscler Thromb Vasc Biol, April 1, 2001; 21(4): 567 - 572. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M.W. Geurts, R. G.J.H. Janssen, M. M.J. van Greevenbroek, C. J.H. van der Kallen, R. M. Cantor, X.-d. Bu, B. E. Aouizerat, H. Allayee, J. I. Rotter, and T. W.A. de Bruin Identification of TNFRSF1B as a novel modifier gene in familial combined hyperlipidemia Hum. Mol. Genet., September 1, 2000; 9(14): 2067 - 2074. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Sartipy, G. Camejo, L. Svensson, and E. Hurt-Camejo Phospholipase A2 Modification of Low Density Lipoproteins Forms Small High Density Particles with Increased Affinity for Proteoglycans and Glycosaminoglycans J. Biol. Chem., September 3, 1999; 274(36): 25913 - 25920. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Tahvanainen, P. Pajukanta, K. Porkka, S. Nieminen, L. Ikavalko, I. Nuotio, M.-R. Taskinen, L. Peltonen, and C. Ehnholm Haplotypes of the ApoA-I/C-III/A-IV Gene Cluster and Familial Combined Hyperlipidemia Arterioscler Thromb Vasc Biol, November 1, 1998; 18(11): 1810 - 1817. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. F. Galeano, M. Al-Haideri, F. Keyserman, S. C. Rumsey, and R. J. Deckelbaum Small dense low density lipoprotein has increased affinity for LDL receptor-independent cell surface binding sites: a potential mechanism for increased atherogenicity J. Lipid Res., June 1, 1998; 39(6): 1263 - 1273. [Abstract] [Full Text]
|
|
|
|
|
|
T. J. Aitman, I. F. Godsland, B. Farren, D. Crook, H. J. Wong, and J. Scott Defects of Insulin Action on Fatty Acid and Carbohydrate Metabolism in Familial Combined Hyperlipidemia Arterioscler Thromb Vasc Biol, April 1, 1997; 17(4): 748 - 754. [Abstract] [Full Text]
|
|
|
|
|
|
W. H. Capell, A. Zambon, M. A. Austin, J. D. Brunzell, and J. E. Hokanson Compositional Differences of LDL Particles in Normal Subjects With LDL Subclass Phenotype A and LDL Subclass Phenotype B Arterioscler Thromb Vasc Biol, August 1, 1996; 16(8): 1040 - 1046. [Abstract] [Full Text]
|
|
|
|
|
|
J. Fan, S. P.A. McCormick, R. M. Krauss, S. Taylor, R. Quan, J. M. Taylor, and S. G. Young Overexpression of Human Apolipoprotein B-100 in Transgenic Rabbits Results in Increased Levels of LDL and Decreased Levels of HDL Arterioscler Thromb Vasc Biol, November 1, 1995; 15(11): 1889 - 1899. [Abstract] [Full Text]
|
|